Valuation : CTT Pharmaceutical Holdings, Inc.

Market Cap 2.94M 2.52M 2.36M 2.16M 4.07M 280M 4.08M 27.94M 10.92M 141M 11.02M 10.78M 468M P/E 2024
-11.9x
P/E 2025 -22.2x
Enterprise Value 2.94M 2.52M 2.36M 2.16M 4.07M 281M 4.09M 27.97M 10.93M 141M 11.03M 10.8M 468M EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
50.43%
Yield 2024 *
-
Yield 2025 -
1 day-8.75%
1 week+25.86%
Current month+14.96%
1 month+19.67%
3 months-8.75%
6 months-6.67%
Current year+21.45%
1 week 0.05
Extreme 0.0459
0.07
1 month 0.04
Extreme 0.0401
0.07
Current year 0.04
Extreme 0.0401
0.1
1 year 0.04
Extreme 0.035
0.1
3 years 0
Extreme 0.0031
0.15
5 years 0
Extreme 0.003
0.15
10 years 0
Extreme 0.003
2.17
Manager TitleAgeSince
Chief Executive Officer - -
Director TitleAgeSince
Director/Board Member 71 2014-09-08
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
8/24/26 BuyCompany 2,100 0.0036%
8/20/26 BuyCompany 11,500 0.0196%
8/19/26 BuyCompany 10,000 0.0170%
Change 5-day change 1-year change 3-year change Capi.($)
-8.75%+25.86%+75.16%+563.64% 2.94M
-0.36%-0.98%+2.95%+23.32% 51.14B
+2.65%+4.45%+481.36%+567.32% 47.4B
+0.33%+2.47%+38.97%+19.80% 43.19B
-0.88%+0.90%+24.11%+87.74% 42.35B
-2.27%-3.02%+14.22%+51.50% 33.23B
-1.21%-0.17%+29.16%+135.38% 17.07B
-0.36%-2.14% - - 16.38B
-0.30%-0.08%+12.25%+28.50% 14.76B
+0.44%+1.70%+82.07%+47.92% 14.15B
Average -1.30%+0.56%+84.47%+169.46% 27.97B
Weighted average by Cap. -0.44%+1.04%+106.28%+143.48%

Financials

2024 2025
Net sales - -
Net income -250K -215K -201K -184K -347K -23.9M -348K -2.38M -931K -12.04M -939K -919K -39.86M -156K -134K -125K -115K -216K -14.89M -217K -1.48M -580K -7.5M -585K -573K -24.84M
Net Debt 16.82K 14.44K 13.52K 12.38K 23.32K 1.61M 23.38K 160K 62.57K 810K 63.15K 61.78K 2.68M 3.46K 2.97K 2.78K 2.54K 4.79K 330K 4.8K 32.88K 12.85K 166K 12.97K 12.69K 550K
Logo CTT Pharmaceutical Holdings, Inc.
CTT Pharmaceutical Holdings, Inc. specializes in drug delivery systems technology within the pharmaceutical industry. Its technology platform includes the development of advanced oral delivery thin wafers to deliver treatment as an alternate to smoking and ingestion. The wafer is an orally administrable paper-thin polymer film used as a carrier for pharmaceutical agents. It rapidly dissolves to release the pharmaceutical agent as soon as it comes in contact with saliva, thus obviating the need for water during administration. Its oral film technology drug delivery system can be provided in various packaging configurations, ranging from unit-dose pouches to multiple-dose blister packages. Its drug delivery system technology includes nicotine, vitamins, pharmaceuticals, and many other actives. It offers oral thin strips for pain management and inflammation indications, such as arthritis. VetWafe is used for pain management for pet markets. It is a thin film for treating dogs and cats.
Employees
-
Date Price Change Volume
26-08-26 US$0.0500 -.--% 16,238
26-08-25 US$0.0500 -12.28% 13,000
26-08-24 US$0.0570 -.--% 21,133
26-08-21 US$0.0570 -1.72% 40,300
26-08-20 US$0.0580 +5.45% 183,788
  1. Stock Market
  2. Stocks
  3. CTTH Stock